Ultimately, it attenuates the ability of the YAP/TAZ complex to interact with TEAD [112–114], resulting in the inactivation of oncogenes such as β-catenin, k-ras, and Akt/mTOR in colon tumor initiation and progression [115–117]. Here, AKT1 is linked to colonic neoplasm.